282 related articles for article (PubMed ID: 2924298)
1. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
Naito M; Tsuruo T
Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
[TBL] [Abstract][Full Text] [Related]
2. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
3. ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.
Naito M; Hamada H; Tsuruo T
J Biol Chem; 1988 Aug; 263(24):11887-91. PubMed ID: 3165378
[TBL] [Abstract][Full Text] [Related]
4. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
5. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
6. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
[TBL] [Abstract][Full Text] [Related]
7. Difference in effects of alkyl-lysophospholipids and verapamil on vincristine transport in vincristine-sensitive and -resistant human myelogenous leukemia K562.
Tsuruo T; Saito H
Anticancer Res; 1987; 7(1):39-43. PubMed ID: 3471174
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562.
Tsuruo T; Oh-Hara T; Saito H
Anticancer Res; 1986; 6(4):637-41. PubMed ID: 3463241
[TBL] [Abstract][Full Text] [Related]
9. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 May; 43(5):2267-72. PubMed ID: 6831450
[TBL] [Abstract][Full Text] [Related]
11. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
[TBL] [Abstract][Full Text] [Related]
13. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic approach against drug-resistant tumors and their biochemical nature].
Tsuruo T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1636-41. PubMed ID: 3592707
[TBL] [Abstract][Full Text] [Related]
15. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
Sehested M; Jensen PB; Skovsgaard T; Bindslev N; Demant EJ; Friche E; Vindeløv L
Br J Cancer; 1989 Dec; 60(6):809-14. PubMed ID: 2605092
[TBL] [Abstract][Full Text] [Related]
17. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
[TBL] [Abstract][Full Text] [Related]
20. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
